Mereo BioPharma Group plc 10-K for FY2023
Mereo BioPharma Group plc (MREO)
10-K
2024-03-27
For: 2023-12-31
View Original
Added on
April 08, 2026
About this 10-K
Mereo BioPharma Group plc filed this 10-K on March 27, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $10M
- compared with $0 a year earlier
- Net loss
- $29.47M
- compared with a net loss of $42.22M a year earlier
- Diluted EPS
- -$0.04
- compared with -$0.07 a year earlier